Outcome Capital Reviews
Cambridge, MA · Founded 2008
- Type
- Tech boutique
- HQ
- Cambridge, MA
- Founded
- 2008
- Deal size
- $10M-$200M
- Focus
- Healthcare Tech, Life Sciences Tech
- Website
- outcomecapital.com
- Yair SchindelCo-Founder, Managing Partner
Outcome Capital is a tech boutique headquartered in Cambridge, MA and founded in 2008. The firm focuses on Healthcare Tech, Life Sciences Tech and typically advises on transactions in the $10M-$200M range. Key dealmakers include Yair Schindel (Co-Founder, Managing Partner). Read founder-verified reviews of Outcome Capital below, from founders who hired the firm as their sell-side advisor whether the deal closed or not.
What to know about Outcome Capital
Outcome Capital has built its franchise in Healthcare Tech, Life Sciences Tech, where founders running a sale process often turn to firms with deep sector pattern recognition. The senior bench, anchored by Yair Schindel, sets the tone for how engagements run from the first call through whatever outcome the process produces. Founders evaluating Outcome Capital typically compare it against other tech boutique houses with similar sector emphasis.
Deal sweet spot at Outcome Capital sits in the $10M-$200M band. That target range shapes everything: which buyers get the call, how the process is paced, and how the firm allocates senior banker attention. Founders working with Outcome Capital should expect a process tuned to that band; founders far below or above it sometimes find a better fit elsewhere.
Geography matters more than founders expect. Outcome Capital operates out of Cambridge, MA, and its strongest buyer-side relationships tend to cluster around that orbit. For sellers running a global process, that can be either an advantage (concentrated relationships) or a constraint (thinner reach in other regions). Founders should ask directly: which buyers have you placed with in the last 24 months, and where are they.
Reviews
Reviews unlock once 5 verified founders have rated this firm. Be the first to break the silence.
Frequently asked questions
- Who can review Outcome Capital?
- Any founder who hired Outcome Capital as their sell-side advisor and ran an M&A process with them, regardless of whether the deal ultimately closed. How a banker behaves when a deal does not close is just as important as when it does, and both outcomes are welcome.
- Has Outcome Capital been reviewed by founders?
- Outcome Capital appears in the BankerNotes directory. Reviews from verified founders who hired the firm unlock publicly once five founders have submitted ratings. Until that threshold is reached, reviews are pending and not displayed.
- Where is Outcome Capital headquartered?
- Outcome Capital is headquartered in Cambridge, MA. The firm was founded in 2008.
- What kinds of deals does Outcome Capital work on?
- Outcome Capital focuses on Healthcare Tech, Life Sciences Tech. Typical transaction size falls in the $10M-$200M range.
- Who are the key dealmakers at Outcome Capital?
- Senior dealmakers include Yair Schindel (Co-Founder, Managing Partner). Founders running a process should expect to interact most with the named partner or managing director assigned to the deal.
- How does BankerNotes verify reviews of Outcome Capital?
- Every review on BankerNotes is submitted by a founder who confirms they hired the firm as their sell-side advisor. We verify the reviewer privately using work email, LinkedIn, and approximate engagement timing. The verified identity is never published. Only the rating, written review, and a generic sector label appear on the public page.
Other Healthcare Tech M&A advisors founders compare with Outcome Capital
More context for Outcome Capital
Compare Outcome Capital with
Last updated: December 24, 2025